Together, these observations suggest that FN1, TLN1, ITGB3, HSPA8, and TUBA4A detection in the blood using SRM/SIS may serve as an indicator of tumors, and elevations in their concentrations coupled with PACSIN2 detection discriminate lung cancer from other malignancies. This evidence concerns the gene PACSIN2 and lung cancer.